Clearside Biomedical Inc (CLSD)
1.31
-0.01
(-0.76%)
USD |
NASDAQ |
May 03, 16:00
1.32
+0.01
(+0.76%)
After-Hours: 20:00
Clearside Biomedical Research and Development Expense (Quarterly): 6.313M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.313M |
| September 30, 2023 | 5.134M |
| June 30, 2023 | 4.948M |
| March 31, 2023 | 4.451M |
| December 31, 2022 | 5.027M |
| September 30, 2022 | 4.637M |
| June 30, 2022 | 5.43M |
| March 31, 2022 | 4.536M |
| December 31, 2021 | 3.84M |
| September 30, 2021 | 5.147M |
| June 30, 2021 | 4.06M |
| March 31, 2021 | 5.49M |
| December 31, 2020 | 4.472M |
| September 30, 2020 | 3.49M |
| June 30, 2020 | 3.30M |
| March 31, 2020 | 3.811M |
| December 31, 2019 | 1.305M |
| September 30, 2019 | 2.728M |
| June 30, 2019 | 0.658M |
| Date | Value |
|---|---|
| March 31, 2019 | 10.97M |
| December 31, 2018 | 17.49M |
| September 30, 2018 | 20.08M |
| June 30, 2018 | 17.34M |
| March 31, 2018 | 13.38M |
| December 31, 2017 | 13.94M |
| September 30, 2017 | 16.05M |
| June 30, 2017 | 11.48M |
| March 31, 2017 | 7.59M |
| December 31, 2016 | 6.971M |
| September 30, 2016 | 3.682M |
| June 30, 2016 | 4.213M |
| March 31, 2016 | 4.589M |
| December 31, 2015 | 3.798M |
| September 30, 2015 | 2.309M |
| June 30, 2015 | 2.147M |
| March 31, 2015 | 2.508M |
| December 31, 2014 | 1.916M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.658M
Minimum
Jun 2019
6.313M
Maximum
Dec 2023
4.146M
Average
4.472M
Median
Dec 2020
Research and Development Expense (Quarterly) Benchmarks
| Cassava Sciences Inc | 18.73M |
| Heron Therapeutics Inc | 10.95M |
| Actinium Pharmaceuticals Inc | 6.635M |
| Karyopharm Therapeutics Inc | 39.38M |
| Ocular Therapeutix Inc | 16.20M |